Stay updated on Nivolumab & Lenvatinib in HCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Lenvatinib in HCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record for nivolumab plus lenvatinib in advanced hepatocellular carcinoma is displayed, including eligibility criteria, treatment details, study outcomes, and record dates.
    Difference
    52%
    Check dated 2026-11-08T13:09:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T13:37:37.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above an unavailable clinical study record.
    Difference
    1%
    Check dated 2026-10-25T13:11:37.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:19:10.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:16:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Displays a 403 Forbidden error instead of the study details, indicating access is blocked and the normal content is replaced by an error message.
    Difference
    19%
    Check dated 2026-09-20T20:13:28.000Z thumbnail image

Stay in the know with updates to Nivolumab & Lenvatinib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.